Crescent Capital BDC, Inc. (CCAP) To Go Ex-Dividend on November 29th

Crescent Capital BDC, Inc. (NASDAQ:CCAP) announced a quarterly dividend on Tuesday, November 12th,Zacks Dividends reports. Shareholders of record on Friday, November 29th will be given a dividend of 0.07 per share on Monday, December 16th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date is Friday, November 29th.

Crescent Capital BDC has a payout ratio of 82.8% meaning its dividend is currently covered by earnings, but may not be in the future if the company’s earnings decline. Analysts expect Crescent Capital BDC to earn $1.99 per share next year, which means the company should continue to be able to cover its $1.68 annual dividend with an expected future payout ratio of 84.4%.

Crescent Capital BDC Stock Down 0.2 %

CCAP opened at $18.78 on Thursday. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.40 and a current ratio of 1.40. The company has a market capitalization of $695.99 million, a PE ratio of 7.37 and a beta of 0.81. The stock’s fifty day moving average is $18.39 and its 200-day moving average is $18.40. Crescent Capital BDC has a one year low of $15.91 and a one year high of $19.63.

Crescent Capital BDC (NASDAQ:CCAP) last issued its quarterly earnings results on Monday, August 12th. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.58 by $0.01. The business had revenue of $48.95 million during the quarter, compared to the consensus estimate of $48.05 million. Crescent Capital BDC had a net margin of 47.06% and a return on equity of 12.20%. During the same quarter in the prior year, the firm earned $0.56 EPS. On average, equities analysts predict that Crescent Capital BDC will post 2.35 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently commented on CCAP shares. Bank of America dropped their price objective on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating on the stock in a report on Thursday, August 15th. Wells Fargo & Company decreased their price target on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 14th. Finally, LADENBURG THALM/SH SH started coverage on Crescent Capital BDC in a research note on Monday, September 30th. They issued a “buy” rating and a $20.00 price objective on the stock. One analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, Crescent Capital BDC currently has a consensus rating of “Moderate Buy” and an average target price of $19.00.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.